Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Neuroblastoma 42Glioblastoma 38Brain Neoplasms 33Glioma 31Central Nervous System Neoplasms 27Gliosarcoma 22Astrocytoma 22Oligodendroglioma 16Medulloblastoma 13Neoplasms 12Rhabdomyosarcoma 7Osteosarcoma 7Recurrence 6Ependymoma 5Diffuse Intrinsic Pontine Glioma 5Sarcoma, Ewing 4Optic Nerve Glioma 4Ganglioneuroblastoma 4Familial ependymoma 4Breast Neoplasms 4Sarcoma 3Rhabdoid Tumor 3Pinealoma 3Pancreatic Neoplasms 3Neurologic Manifestations 3Neuroectodermal Tumors, Primitive, Peripheral 3Colonic Neoplasms 3Choroid Plexus Neoplasms 3Bone Neoplasms 3Wilms Tumor 2

Interventions

trametinib 2dabrafenib 2mirdametinib 1gallium Ga 68 dotatate 1Vincristine 1Magnetic Resonance Spectroscopy 1Irinotecan 1Ga(III)-DOTATOC 1Carboplatin 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Ganglioneuroma × Irinotecan × CNS × Clear all
NCT01999270 2016-10-21

Evaluation of FDOPA-PET/MRI in Pediatric Patients With CNS Tumors

Washington University School of Medicine

Phase 1 Completed
6 enrolled
CNS

Astrocytoma, Ganglioneuroma, Glioma, Ganglioglioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡